References
- Arnutti P, Kotepui M, Asanprakit W, et al (2013). Determination of whole transcription profiles and specific pathways in invasive ductal breast carcinoma. Int J Clin Exp Pathol, 6, 1112-20.
- Al-Kuraya K, Schraml P, Torhorst J, et al (2004). Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res, 64, 8534-40. https://doi.org/10.1158/0008-5472.CAN-04-1945
- Berry DA, Cronin KA, Plevritis SK, et al (2005). Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med, 353, 1784-92. https://doi.org/10.1056/NEJMoa050518
- Blackwell KL, Burstein HJ, Storniolo AM, et al (2010). Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumabrefractory metastatic breast cancer. J Clin Oncol, 28, 1124-30. https://doi.org/10.1200/JCO.2008.21.4437
- Chuthapisith S, Permsapaya W, Warnnissorn M, et al (2012). Breast cancer subtypes identified by the ER, PR and HER-2 status in Thai women. Asian Pac J Cancer Prev, 13, 459-62. https://doi.org/10.7314/APJCP.2012.13.2.459
- De Giorgi U, Rosti G, Frassineti L, et al (2007). High-dose chemotherapy for triple negative breast cancer. Ann Oncol, 18, 202-3.
- de Snoo F, Bender R, Glas A, Rutgers E (2009). Gene expression profiling: decoding breast cancer. Surg Oncol, 18, 366-78. https://doi.org/10.1016/j.suronc.2009.07.005
- Eeckhoute J, Carroll JS, Geistlinger TR, Torres-Arzayus MI, Brown M (2006). A cell-type specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes Dev, 20, 2513-26. https://doi.org/10.1101/gad.1446006
- Edge SB, Compton CC (2010). The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 17, 1471-4. https://doi.org/10.1245/s10434-010-0985-4
- Ekpanyaskul C, Khuhaprema T, Wiangnon S, Sangrajrang S (2010). Case-control study of occupational categories and breast cancer risk in Thailand. Asian Pac J Cancer Prev, 11, 793-7.
- Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
- Fitzgibbons PL, Page DL, Weaver D, et al (2000). Prognostic factors in breast cancer. college of american pathologists consensus statement 1999. Arch Pathol Lab Med, 124, 966-78.
- Frkovic-Grazio S, Bracko M (2002). Long term prognostic value of Nottingham histological grade and its components in early (pT1N0M0) breast carcinoma. J Clin Pathol, 55, 88-92. https://doi.org/10.1136/jcp.55.2.88
- Ginzinger DG (2002). Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol, 30, 503-12. https://doi.org/10.1016/S0301-472X(02)00806-8
- Goda E, Kamiyama S, Uno T, et al (2006). Identification and characterization of a novel Drosophila 3'-phosphoadenosine 5'-phosphosulfate transporter. J Biol Chem, 281, 28508-17. https://doi.org/10.1074/jbc.M605045200
- Huopaniemi L, Kolmer M, Niittymaki J, Pelto-Huikko M, Renkonen R (2004). Inflammation-induced transcriptional regulation of Golgi transporters required for the synthesis of sulfo sLex glycan epitopes. Glycobiology, 14, 1285-94. https://doi.org/10.1093/glycob/cwh131
- Ismail-Khan R, Bui MM (2010). A review of triple-negative breast cancer. Cancer Control, 17, 173-6.
- Jana D, Mandal S, Mukhopadhyay M, et al (2012). Prognostic significance of HER-2/neu and survival of breast cancer patients attending a specialized breast clinic in Kolkata, Eastern India. Asian Pac J Cancer Prev, 13, 3851-5. https://doi.org/10.7314/APJCP.2012.13.8.3851
- Kamiyama S, Suda T, Ueda R, et al (2003). Molecular cloning and identification of 3'-phosphoadenosine 5'-phosphosulfate transporter. J Biol Chem, 278, 25958-63. https://doi.org/10.1074/jbc.M302439200
- Kamiyama S, Sasaki N, Goda E, et al (2006). Molecular cloning and characterization of a novel 3'-phosphoadenosine 5'-phosphosulfate transporter, PAPST2. J Biol Chem, 281, 10945-53. https://doi.org/10.1074/jbc.M508991200
- Kamiyama S, Ichimiya T, Ikehara Y, et al (2011). Expression and the role of 3'- phosphoadenosine 5'-phosphosulfate transporters in human colorectal carcinoma. Glycobiology, 21, 235-46. https://doi.org/10.1093/glycob/cwq154
- Kenemans P, Verstraeten RA, Verheijen RH (2008). Oncogenic pathways in hereditary and sporadic breast cancer. Maturitas, 61, 141-50. https://doi.org/10.1016/j.maturitas.2008.11.010
- Khuhaprema T, Srivatanakul P, Sriplung H, et al (2006). Bangkok cancer registry. In 'Cancer in Thailand Vol. IV, 1998-2000' Bangkok Medical Publisher, Bangkok pp 7-21.
- Khuhaprema T, Srivatanakul P, Sriplung H, et al (2010). Bangkok cancer registry. In 'Cancer in Thailand Vol. V, 2001-2003' Bangkok Medical Publisher, Bangkok pp 113-8.
- Kotepui M, Chupeerach C (2013). Age distribution of breast cancer from a Thailand population-based cancer registry. Asian Pac J Cancer Prev, 14, 3815-17. https://doi.org/10.7314/APJCP.2013.14.6.3815
- Kotepui M, Thawornkuno C, Chavalitshewinkoon-Petmitr P, Punyarit P, Petmitr S (2012). Quantitative real-time RTPCR of ITGA7, SVEP1, TNSI1, LPHN3, SEMA3G, KLB and MMP13 mRNA expression in breast cancer. Asian Pac J Cancer Prev, 13, 5879-82. https://doi.org/10.7314/APJCP.2012.13.11.5879
- Kuderer NM, Lyman GH (2009). Gene expression profile assays as predictors of distant recurrence-free survival in early-stage breast cancer. Cancer Invest, 27, 885-90. https://doi.org/10.3109/07357900903275142
- Li CY, Zhang S, Zhang XB, et al (2013). Clinicopathological and prognostic characteristics of triple- negative breast cancer (TNBC) in Chinese patients: a retrospective study. Asian Pac J Cancer Prev, 14, 3779-84. https://doi.org/10.7314/APJCP.2013.14.6.3779
- Li H, Deyrup A, Mensch JR Jr, et al (1995). The isolation and characterization of cDNA encoding the mouse bifunctional ATP sulfurylase-adenosine 5'-phosphosulfate kinase. J Biol Chem, 270, 29453-9. https://doi.org/10.1074/jbc.270.49.29453
- Liu AN, Sun P, Liu JN, et al (2012). Clinicopathologic characteristics and prognostic factors in patients with operable HER-2 overexpressing breast cancer. Asian Pac J Cancer Prev, 13, 1197-201. https://doi.org/10.7314/APJCP.2012.13.4.1197
- Luders F, Segawa H, Stein D, et al (2003). Slalom encodes an adenosine 3'-phosphate 5'-phosphosulfate transporter essential for development in drosophila. EMBO J, 22, 3635-44. https://doi.org/10.1093/emboj/cdg345
- Moore MA, Attasara P, Khuhaprema T, et al (2008). Cancer epidemiology in mainland south-east asia-past, present and future. Asian Pac J Cancer Prev, 10, 67-80.
- Madjd Z, Akbari ME, Zarnani AH, et al (2014). Expression of EMSY, a novel BRCA2-link protein, is associated with lymph node metastasis and increased tumor size in breast carcinomas. Asian Pac J Cancer Prev, 15, 1783-9. https://doi.org/10.7314/APJCP.2014.15.4.1783
- Nair R, Roden DL, Teo WS, et al (2013). c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer. Oncogene, (Epub ahead of print).
- Nakayama F, Umeda S, Ichimiya T, et al (2013). Sulfation of keratan sulfate proteoglycan reduces radiation-induced apoptosis in human Burkitt's lymphoma cell lines. FEBS Lett, 587, 231-7. https://doi.org/10.1016/j.febslet.2012.12.002
- Olivotto IA, Chua B, Allan SJ, et al (2003). Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer. J Clin Oncol, 21, 851-4. https://doi.org/10.1200/JCO.2003.11.105
- Pakkiri P, Lakhani SR, Smart CE (2009). Current and future approach to the pathologist's assessment for targeted therapy in breast cancer. Pathology, 41, 89-99. https://doi.org/10.1080/00313020802563551
- Reed W, Hannisdal E, Boehler PJ, et al (2000). The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years. Cancer, 88, 804-13. https://doi.org/10.1002/(SICI)1097-0142(20000215)88:4<804::AID-CNCR11>3.0.CO;2-Y
- Sriplung H, Wiangnon S, Sontipong S, Sumatsawan Y, Martin M (2006). Cancer incidence trends in Thailand, 1989-2000. Asian Pac J Cancer Prev, 7, 118-25.
- Singletary SE, Allred C, Ashley P, et al (2002). Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol, 20, 3628-36. https://doi.org/10.1200/JCO.2002.02.026
- Taneja P, Maglic D, Kai F, et al (2010). Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance. Clin Med Insights Oncol, 4, 15-34.
- Woodward WA, Strom EA, Tucker SL, et al (2003). Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol, 21, 3244-8. https://doi.org/10.1200/JCO.2003.03.052
- Yu D, Hung MC (2000). Over-expression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene, 19, 6115-21. https://doi.org/10.1038/sj.onc.1203972
- Zhang H, Jin F (2010). HER-2 expression correlates with survivin in primary invasive ductal breast cancers. Asian Pac J Cancer Prev, 11, 1201-4.